Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERMES Pilot Study of short-acting insulin analogs and regular human insulin in type 2 diabetes
2011-003733-34Phase 4Completed
- Sponsor
- IKFE
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin glulisine, insulin aspart and human insulin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by IKFE. Primary endpoint: Nitrotyrosine. Started Aug 2011; status: completed.
02
Drugs
insulin glulisineinsulin asparthuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-003733-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003733-34.